While global and domestic demand concerns persist, analysts believe strategic investments arising from inorganic opportunities will drive growth.

The U.S. market for exchange-listed equity option contracts was headed for another year of record-breaking trading volume in 2024 - its fifth in a row, according to data from the Options Clearing ...

LIVE: Benchmark Indian equity indices BSE Sensex and Nifty50 were trading lower on Friday, amid mixed global cues and a lower ...

Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True North.